Monoclonal antibody therapy for breast cancer: herceptin.

M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)

C. Wallasch, F. U. Weiss, G. Niederfellner, B. Jallal, W. Issing, A. Ullrich, Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. The EMBO Journal. ,vol. 14, pp. 4267- 4275 ,(1995) , 10.1002/J.1460-2075.1995.TB00101.X

RA Miller, AR Oseroff, PT Stratte, R Levy, Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma Blood. ,vol. 62, pp. 988- 995 ,(1983) , 10.1182/BLOOD.V62.5.988.988

Theodore A. Slaman, Relative to any nonrecursive set Proceedings of the American Mathematical Society. ,vol. 126, pp. 2117- 2122 ,(1998) , 10.1090/S0002-9939-98-04307-X

Mark M. Moasser, Steven D. Averbuch, Neal Rosen, Andrea Basso, The Tyrosine Kinase Inhibitor ZD1839 ("Iressa") Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Tumor Cells Cancer Research. ,vol. 61, pp. 7184- 7188 ,(2001)

Eric P. Winer, Harold J. Burstein, Irene Kuter, Susana M. Campos, Rebecca S. Gelman, Laura Tribou, Leroy M. Parker, Judith Manola, Jerry Younger, Ursula Matulonis, Craig A. Bunnell, Ann H. Partridge, Paul G. Richardson, Kathryn Clarke, Lawrence N. Shulman, Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 2722- 2730 ,(2001) , 10.1200/JCO.2001.19.10.2722

Gwi Eon Kim, Jae Ho Cho, Woo Ick Yang, Eun Ji Chung, Chang Ok Suh, Kyung Ran Park, Won Pyo Hong, In Yong Park, Jee Sook Hahn, Jae Kyung Roh, Byung Soo Kim, Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation Treatment Journal of Clinical Oncology. ,vol. 18, pp. 54- 63 ,(2000) , 10.1200/JCO.2000.18.1.54

Daniel Harari, Yosef Yarden, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. ,vol. 19, pp. 6102- 6114 ,(2000) , 10.1038/SJ.ONC.1203973

J.-M. Nabholtz, T. Pienkowski, D. Nothfelt, W. Eiermann, E. Quan, P. Fumoleau, R. Patel, J. Crown, D. Toppmeyer, D. Slamon, Results of two open label Multicentre phase II pilot studies with Herceptin in combination with docetaxel and platinum salts (Cis or Carboplatin) (TCH) as Therapy for Advanced Breast Cancer (ABC) in women with tumors over-expressing the HER2-neu proto-oncogene European Journal of Cancer. ,vol. 37, ,(2001) , 10.1016/S0959-8049(01)81187-4

P. Di Fiore, J. Pierce, M. Kraus, O Segatto, C. King, S. Aaronson, erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science. ,vol. 237, pp. 178- 182 ,(1987) , 10.1126/SCIENCE.2885917